In a report published in the International Journal of Cancer researchers found that a vitamin D formulation D5 combined with antibodies against the Her-2 protein killed Her-2-positive breast cancer cells in both laboratory experiments and in mice. The researchers are currently testing whether Herceptin a humanized Her-2 antibody combined with D5 is more effective than either agent given alone.
|
PAUL IS THIS THE REGULAR VIT. D THAT I CAN GET AT THE HEALTH FOOD STORE. DOES IT SAY HOW MUCH YOU NEED TO TAKE PER DAY? ZO
|
All times are GMT -7. The time now is 01:56 PM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2024, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021